Morning Wire Thursday | October 7, 2021
Oct 7, 2021
COVID-19 cases are in decline, but the conversation is heating up around a new Merck treatment that significantly reduces mortality rates. The Biden administration has made major shifts in abortion funding policy, reversing prior restrictions. Meanwhile, tensions rise with the DOJ labeling concerned parents as domestic threats, stirring debate around educational policies and government oversight. This podcast dives into how these developments could reshape public health and political landscapes.
AI Snips
Chapters
Transcript
Episode notes
Molnupiravir: A COVID Game-Changer
- Molnupiravir, Merck's new COVID pill, is a game-changer.
- It dramatically reduces deaths, is safe, cheap, and works against all variants.
Natural Immunity vs. Vaccinated Immunity
- Natural immunity is now shown to be much stronger than vaccinated immunity.
- Data from Israel reveals it's 27 times more effective, supported by other studies.
Recognize Natural Immunity
- Recognize natural immunity in public health protocols, like in Europe and Israel.
- Give credit for circulating antibodies to avoid ruining lives of the naturally immune.